Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neoplasms of the CNS

Free Subscription 12.01.2026 2 AJNR Am J Neuroradiol 1 Br J Cancer 1 Brain 1 Cancer 2 Childs Nerv Syst 1 Int J Cancer 13 J Neurooncol 1 J Nucl Med 4 Neuro Oncol 2 Neurol Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. SASAKI M, Teraoka Y, Kato A, Nakajima T, et al
   Digital FDG-PET detects MYD88 mutation-driven glycolysis in primary central nervous system lymphoma.
   AJNR Am J Neuroradiol. 2025 Jul 21:ajnr.A8935. doi: 10.3174/ajnr.A8935.
   PubMed         Abstract available
   
   
2. YOUNG CC, Narsinh KH, Chen SR, Ansari SA, et al
   A Report from the Inaugural Society of NeuroInterventional Surgery Neurointerventional Oncology Summit.
   AJNR Am J Neuroradiol. 2026;47:1-8.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. ALRASHIDI M, Ferro F, Almohammadi A, Alyoubi NH, et al
   Efficacy and safety of low- and high-intensity focused ultrasound in glioblastoma: a systematic review of preclinical and clinical studies.
   Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03325.
   PubMed         Abstract available
   
   

   
   Brain

4. MENACEUR VANDENBROUCKE C, Unnikrishnan K, Itak Ita M, Lassen UN, et al
   Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma.
   Brain. 2026 Jan 6:awag003. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Cancer

5. ZHAO W, Li L, Fu X, Chang Y, et al
   A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.
   Cancer. 2026;132:e70247.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. LINO-FILHO AM, da Silva Andrade WM, de Morais WJ, Amorim JBS, et al
   Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the treatment of hydrocephalus due to posterior fossa tumors in children: an updated meta-analysis.
   Childs Nerv Syst. 2026;42:9.
   PubMed         Abstract available
   
   
7. SATO H, Kanno M, Ito M, Ichimura K, et al
   A congenital infant-type hemispheric glioma case with EML4::ALK fusion.
   Childs Nerv Syst. 2026;42:1.
   PubMed         Abstract available
   
   

   
   Int J Cancer

8. ZHAO J, Li T, Jing Y, Yang H, et al
   Regulation of endoplasmic reticulum-mitochondria transfer and its importance in GBM.
   Int J Cancer. 2026;158:1166-1177.
   PubMed         Abstract available
   
   

   
   J Neurooncol

9. LIU CM, Medeiros Geraldo LH, Xiao J, Sulman EP, et al
   Retrospective analysis of the impact of antidepressants with anti-acid sphingomyelinase activity on survival of patients with glioblastoma.
   J Neurooncol. 2026;176:147.
   PubMed        
   
   
10. HONG JP, Hong JB, Lee B, Choi RJ, et al
    Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres.
    J Neurooncol. 2026;176:148.
    PubMed        
    
    
11. ZHOU L, Xu Z, Fang C, Ren H, et al
    Multiomics reveals the mechanism of KNG1 in promoting tumor progression in adamantinomatous craniopharyngioma.
    J Neurooncol. 2026;176:150.
    PubMed        
    
    
12. SANIKOMMU S, Santos AN, Wipplinger C, Dawoud B, et al
    Patient-reported outcomes as prognostic indicators for overall survival and progression-free survival in brain tumor patients - a systematic review and meta-analysis of randomized clinical trials.
    J Neurooncol. 2026;176:154.
    PubMed         Abstract available
    
    
13. GU M, Luckett PH, Olufawo M, Dierker D, et al
    BOLD complexity characterizes glioblastoma survival via voxel-wise and localized sample entropy.
    J Neurooncol. 2026;176:151.
    PubMed         Abstract available
    
    
14. AKBAS S, Alan O, Yildiz O, Karakurt M, et al
    Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
    J Neurooncol. 2026;176:152.
    PubMed        
    
    
15. TINI P, Donnini F, Minniti G
    EGFR amplification and rapid early progression in glioblastoma: implications for timing and risk stratification.
    J Neurooncol. 2026;176:155.
    PubMed        
    
    
16. CHEN S, Jugl S, Jackson L, Rahman M, et al
    Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users.
    J Neurooncol. 2026;176:156.
    PubMed        
    
    
17. HU W, Rao Q, Zhu D, Yao S, et al
    Clinicopathological features and outcomes in non-functioning pituitary neuroendocrine tumors: a transcription factor-driven subtype analysis.
    J Neurooncol. 2026;176:160.
    PubMed         Abstract available
    
    
18. HARPER SD, Alderete JA, Baisiwala S, Bergsneider BH, et al
    Vaccine therapy for pediatric high-grade glioma: current landscape, challenges, and future directions.
    J Neurooncol. 2026;176:158.
    PubMed         Abstract available
    
    
19. ROBINSON SD, Kingdon S, Williams ST, Hill CS, et al
    Understanding the difference in symptoms and outcomes between glioblastoma patients diagnosed based on histological or molecular criteria: a retrospective cohort analysis from the Histo-Mol GBM collaborative.
    J Neurooncol. 2026;176:157.
    PubMed         Abstract available
    
    
20. FORTUNATO JT, Scharf A, Shuman AG, Diamond EL, et al
    Staging prognostic discussions about glioblastoma.
    J Neurooncol. 2026;176:162.
    PubMed         Abstract available
    
    
21. NAKAJIMA R, Kinoshita M, Okita H, Tamai S, et al
    Surgical history and temporal muscle thickness as predictors of successful awake surgery in older patients with glioma.
    J Neurooncol. 2026;176:161.
    PubMed        
    
    

    
    J Nucl Med

22. WERNER JM, Lohmann P, Kabbasch C, Wollring MM, et al
    Assessment of Response to Regorafenib in Patients with Glioma Relapse Using (18)F-FET PET and MRI.
    J Nucl Med. 2026 Jan 8:jnumed.125.270946. doi: 10.2967/jnumed.125.270946.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

23. KHAN I, Kumar D, Zhang W, Difilippantonio S, et al
    Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier and distribution to tumor cells in HER2+ brain metastasis model systems.
    Neuro Oncol. 2026 Jan 7:noag002. doi: 10.1093.
    PubMed         Abstract available
    
    
24. SILVERBUSH D, Jurgensen L, Freeburg NF, Pooley CS, et al
    A cellular epigenetic classification system for glioblastoma.
    Neuro Oncol. 2026 Jan 7:noaf299. doi: 10.1093.
    PubMed         Abstract available
    
    
25. DENG B, Head R, Draaisma K, Hoeben A, et al
    Epigenetic evolution of IDHwt glioblastomas.
    Neuro Oncol. 2026 Jan 2:noaf298. doi: 10.1093.
    PubMed         Abstract available
    
    
26. WU F, Yin YY, Wang D, Pan CQ, et al
    Metabolic Profiling Defines Glioblastoma Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities.
    Neuro Oncol. 2026 Jan 2:noaf294. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

27. SUN Y, Aisha A, Qu Y, Zhu Y, et al
    Study on the mechanism of TMZ resistance in brain glioma regulated by copper death.
    Neurol Res. 2026 Jan 5:1-9. doi: 10.1080/01616412.2025.2611013.
    PubMed         Abstract available
    
    
28. DENG J, Liu J, Chen Y, Qi Y, et al
    Perioperative deep venous thrombosis prophylaxis in patients with glioblastoma: a propensity score-matched comparative study.
    Neurol Res. 2026 Jan 5:1-10. doi: 10.1080/01616412.2026.2612761.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.